What is Caprolactam Chemicals Ltd (507486) share price return in the past 10 years?

Caprolactam Chemicals Ltd share price has appreciated 16.2% annually (CAGR) over the past ten years.

What is the share price of Caprolactam Chemicals Ltd (507486)?

Company share prices are keep on changing according to the market conditions. The current trading price of Caprolactam Chemicals Ltd (507486) on 06-Jul-2026 16:59:59 at 16:59 is 49.27.

What is the P/E ratio of Caprolactam Chemicals?

The latest standalone P/E ratio of Caprolactam Chemicals as of 06-Jul-2026 is 12.86.

What is the P/B ratio of Caprolactam Chemicals Ltd (507486)?

The latest standalone P/B ratio of Caprolactam Chemicals Ltd (507486) as of 06-Jul-2026 is 3.44.

What is the 52-week high and low of Caprolactam Chemicals Ltd (507486)?

The 52-week high of Caprolactam Chemicals Ltd (507486) is Rs. 81.00 and the 52-week low is Rs. 38.10.

Caprolactam Chemicals Ltd (507486)

Name: Caprolactam Chemicals Ltd (507486)
Brand: Caprolactam Chemicals

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 507486 NSE: Chemicals | Small Cap | Caprolactam Chem. Share Price

₹49.27 2.34 (4.99%)

As on 06-Jul'26 16:59

Caprolactam Chemicals Ltd (507486)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 507486 NSE: Chemicals | Small Cap | Caprolactam Chem. Share Price

₹49.27 2.34 (4.99%)

As on 06-Jul'26 16:59

Key Metrics

Valuation Multiples

Market Cap

₹23 Cr.

Current Price

₹49.3

52-Week Low / High

₹38 / 81

TTM EPS

₹3.8

TTM Sales

₹10.6 Cr.

Book Value per Share

₹14.3

P/E Ratio

12.86

In line with its 5-year historical median

Industry PE

52.9

Price to Book (P/B)

3.44

Lower than its 5-year historical median

Price to Sales (P/S)

2.15

Lower than its 5-year historical median

EV/EBITDA

7.07

Lower than its 5-year historical median

Dividend Yield

Profitability Efficiency

Return on Equity (ROE)

-13.66%

Underperforms industry median

Return on Capital Employed (ROCE)

-0.44%

Underperforms industry median

Return on Assets (ROA)

-5.46%

Operating Profit Margin

22.6%

Net Profit Margin

-10.52%

Gross Profit Margin

13.4%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-3.16%

Operating Profit Growth (1 Year)

-29.95%

Net Profit Growth (1 Year)

-455%

Asset Quality

Promoter Holding

54.50%

Pledged shares (%) of Promoter's holding (%)

0.00%

Reserves

₹2 Cr.

Equity

₹4.6 Cr.

Face Value

₹10

All Time Low / High

₹0.20 / 113.25

Caprolactam Chemicals stock performance

Key Ratios

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Caprolactam Chemicals Ltd a good quality company?

Caprolactam Chemicals Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does Caprolactam Chemicals Ltd performance compare with that of its Peers?

Q.1 Revenue growth of Caprolactam Chemicals Ltd vs industry peers?

Caprolactam Chemicals Ltd revenue CAGR is 0.70%, compared to the industry median CAGR of 7.53%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of Caprolactam Chemicals Ltd?

Promoters hold 54.50% of the Caprolactam Chemicals Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Q.1 Stock return of Caprolactam Chemicals Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 15.1% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	27.4%	0.3%	11%	19.6%	25.8%	19.5%	-18.7%	40.3%	6.9%	-0.4%	-
Value Creation Index ⓘ	1.0	-1.0	-0.2	0.4	0.8	0.4	-2.3	1.9	-0.5	-1.0	-
Growth Parameters ⓘ
Sales ⓘ	4.9	3.2	4.1	5.2	6.5	6.3	2.1	9.8	7	6.7	11
Sales YoY Gr.	-	-33.6%	25.6%	27.5%	25.4%	-3.1%	-67.2%	375.4%	-29.3%	-3.2%	-
Adj EPS ⓘ	1.1	-0.3	0.4	1.1	2.1	1.4	-2.8	5.5	0.4	-1.5	3.8
YoY Gr.	-	-121.9%	NA	186.8%	89.9%	-31.9%	-297.9%	NA	-92.2%	-458.1%	-
BVPS (₹) ⓘ	4.3	4.1	4.4	5.5	7.6	8.9	6.1	11.6	12.1	10.5	14.3
Adj Net Profit ⓘ	0.5	-0.1	0.2	0.5	1	0.7	-1.3	2.6	0.2	-0.7	2
Cash Flow from Ops. ⓘ	0.6	0.5	1.1	3	2.2	1.3	3.1	0.9	1.8	-0.6	-
Debt/CF from Ops. ⓘ	1.6	2.6	1.7	1.2	1.1	1.7	1.2	6.6	3.2	-14	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	3.7%	0.7%	48.2%	-3.2%
Adj EPS ⓘ	-203.4%	-194.3%	NA	-458.1%
BVPSⓘ	10.4%	6.7%	20%	-12.9%
Share Price	16.2%	-14.5%	-7.3%	24%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	30.5	-6	8.9	21.9	31.5	17.2	-37.3	62.6	3.6	-13.7	30.9
Op. Profit Mgn % ⓘ	17	14.5	22	36.3	38.7	34.3	-27.4	47.5	31.2	22.6	42.3
Net Profit Mgn % ⓘ	10.7	-3.6	4.3	9.7	14.6	10.3	-62	25.9	2.8	-10.5	16.7
Debt to Equity ⓘ	0.5	0.7	0.9	1.4	0.7	0.5	1.3	1.1	1.1	1.8	0
Working Cap Days ⓘ	44	91	123	93	40	54	189	38	62	140	96
Cash Conv. Cycle ⓘ	-7	-12	-9	-35	-39	-6	15	-8	25	89	10

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	4.88	3.24	4.07	5.19	6.51	6.31	2.07	9.84	6.96	6.74
Operating Expenses ⓘ +	4.05	2.77	3.17	3.31	3.99	4.15	2.63	5.17	4.78	5.22
Manufacturing Costs	3.17	2.37	2.17	2.23	2.95	3.25	1.37	3.67	3.32	2.89
Material Costs	0.11	-0.19	0.36	0.37	0.01	0.13	0.53	0.61	0.49	1.34
Employee Cost	0.16	0.16	0.18	0.23	0.23	0.31	0.25	0.35	0.30	0.34
Other Costs ⓘ	0.61	0.44	0.47	0.48	0.80	0.46	0.48	0.54	0.68	0.65
Operating Profit ⓘ	0.83	0.47	0.90	1.88	2.52	2.16	-0.57	4.68	2.17	1.52
Operating Profit Margin (%)	17.0%	14.5%	22.0%	36.3%	38.7%	34.3%	-27.4%	47.5%	31.2%	22.6%
Other Income ⓘ +	0.40	0.01	0.07	0.07	0.06	0.09	0.41	0.02	0.18	0.01
Exceptional Items ⓘ	-0	0	-0	0	0	0	0	0	0	0
Interest ⓘ	0.11	0.12	0.19	0.34	0.30	0.30	0.28	0.57	0.50	0.63
Depreciation ⓘ	0.51	0.47	0.57	0.97	1.02	1.07	1.03	1.15	1.58	1.59
Profit Before Tax ⓘ	0.61	-0.12	0.20	0.64	1.26	0.89	-1.47	2.97	0.27	-0.68
Tax ⓘ	0.09	0	0.03	0.14	0.31	0.24	-0.19	0.42	0.08	0.03
Profit After Tax	0.52	-0.12	0.17	0.50	0.95	0.65	-1.28	2.55	0.20	-0.71
PAT Margin (%)	10.7%	-3.6%	4.2%	9.7%	14.6%	10.3%	-62.0%	25.9%	2.8%	-10.5%
Adjusted EPS (₹)	1.1	-0.3	0.4	1.1	2.1	1.4	-2.8	5.5	0.4	-1.5
Dividend Payout Ratio (%)	0%	0%	0%	0%	0%	0%	0%	0%	0%	0%

Valuation of Caprolactam Chem. - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	1.98	1.86	2.03	2.54	3.50	4.08	2.80	5.34	5.55	4.83
Share Capital ⓘ	4.59	4.59	4.59	4.60	4.60	4.60	4.60	4.60	4.60	4.60
Reserves ⓘ	-2.61	-2.73	-2.56	-2.06	-1.10	-0.52	-1.80	0.74	0.95	0.23
Debt +	0.95	1.37	1.89	3.58	2.45	2.15	3.75	5.69	5.86	8.71
Long Term Debt	0	0	0	0	0	0	2.75	2.67	0	0
Short Term Debt	0.95	1.37	1.89	3.58	2.45	2.15	1	3.02	5.86	8.71
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	0.50	0.83	0.85	0.81	0.50	0.40	0.50	0.29	0.15	0.44
Others Liabilities ⓘ	0.47	0.26	1.49	0.48	0.66	0.57	3.28	0.20	0.09	0.30
Total Liabilities ⓘ	3.91	4.32	6.27	7.41	7.11	7.20	10.33	11.52	11.65	14.28
Fixed Assets
Net Fixed Assets ⓘ +	2.96	3.38	3.56	6.37	6.07	5.50	5.26	10.22	10.29	10.31
Gross Block	8.27	9.15	9.91	13.68	14.41	14.90	15.70	21.81	23.47	25.13
Accumulated Depreciation	5.31	5.78	6.35	7.32	8.34	9.41	10.44	11.59	13.17	14.82
CWIP ⓘ	0	0	0	0	0	0	3.96	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	0.08	0.27	0.30	0.09	0.08	0.11	0.12	0.09	0.07	0.41
Trade Receivables	0.52	0.36	0.77	0.04	0.30	0.47	0.03	0.68	0.64	2.82
Cash Equivalents	0.16	0.11	0.79	0.32	0.34	0.52	0.15	0.23	0.09	0.08
Others Assets ⓘ	0.19	0.20	0.85	0.59	0.32	0.60	0.81	0.31	0.57	0.66
Total Assets ⓘ	3.91	4.32	6.27	7.41	7.11	7.20	10.33	11.52	11.65	14.28

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	0.58	0.54	1.10	2.96	2.18	1.25	3.05	0.86	1.82	-0.62
PBT ⓘ	0.61	-0.12	0.20	0.64	1.26	0.89	-1.47	2.97	0.27	-0.68
Adjustment ⓘ	0.62	0.59	0.76	1.31	1.32	1.35	1.31	1.71	2.07	2.21
Changes in Working Capital ⓘ	-0.55	0.06	0.18	1.13	-0.27	-0.51	3.54	-3.44	-0.44	-2.14
Tax Paid ⓘ	-0.10	0	-0.04	-0.13	-0.13	-0.48	-0.32	-0.38	-0.08	-0
Cash Flow From Investing Activity ⓘ +	-0.56	-0.89	-0.75	-3.78	-0.73	-0.48	-4.75	-2.14	-1.64	-1.60
Capex	-0.56	-0.89	-0.75	-3.78	-0.73	-0.49	-4.75	-2.16	-1.65	-1.61
Net Investments	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0	0	0	0	-0.01	0.01	0.01	0.02	0.01	0.01
Cash Flow From Financing Activity ⓘ +	0.02	0.30	0.33	0.35	-1.43	-0.59	1.33	1.37	-0.32	2.22
Net Proceeds from Shares ⓘ	0	0	0	0.01	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	0	0	0	0	0	0	0	0	0
Interest Paid ⓘ	-0.10	-0.12	-0.19	-0.34	-0.30	-0.30	-0.28	-0.57	-0.50	-0.63
Dividend Paid ⓘ	0	0	0	0	0	0	0	0	0	0
Others ⓘ	0.13	0.42	0.52	0.68	-1.13	-0.30	1.60	1.93	0.18	2.85
Net Cash Flow ⓘ	0.05	-0.05	0.68	-0.47	0.02	0.18	-0.37	0.08	-0.14	-0

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	30.31	-6.01	8.83	21.91	31.49	17.17	-37.28	62.62	3.63	-13.66
ROCE (%)	27.38	0.26	10.97	19.63	25.81	19.53	-18.7	40.26	6.87	-0.44
Asset Turnover Ratio	1.33	0.79	0.77	0.76	0.9	0.88	0.24	0.9	0.6	0.52
PAT to CFO Conversion(x)	1.12	N/A	6.47	5.92	2.29	1.92	N/A	0.34	9.1	N/A
Working Capital Days
Receivable Days	19.90	49.40	50.60	28.50	9.50	22.30	44.40	13.10	34.40	93.70
Inventory Days	9.90	19.40	25.70	13.90	4.90	5.50	20.30	3.90	4.10	12.80
Payable Days	1,324	-1,255.50	850.90	819.20	0	1,260.20	307.50	235.70	164.90	80.20

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Caprolactam Chemicals Ltd FAQs

The current trading price of Caprolactam Chem. on 06-Jul-2026 16:59 is ₹49.27.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 05-Jul-2026 the market cap of Caprolactam Chem. stood at ₹22.66 Cr

The latest P/E ratio of Caprolactam Chem. as of 05-Jul-2026 is 12.86.

The latest P/B ratio of Caprolactam Chem. as of 05-Jul-2026 is 3.44.

The 52-week high of Caprolactam Chem. is ₹81.00 and the 52-week low is ₹38.10.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Caprolactam Chem. is ₹10.56 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Caprolactam Chemicals Ltd is a average quality company.

The key valuation ratios of Caprolactam Chemicals Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Caprolactam Chemicals Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Caprolactam Chemicals Ltd

Vamotiwala Chemical Industries Limited was originally incorporated on the November 18, 1988 as a Private Limited Company and was converted into a Public Limited Company on the April 15, 1992. Since December 1988, the company has been involved in a phased manner, in activities relating to setting up a project for manufacture of Glycol Ether, Ethylene Oxide Condensate Emulsifier, Vinyl Sulphone and Ethyl Acetate.

The first module of project consisting of Glycol Ether and Ethylene oxide condensate emulsifier plants was put into commercial operation during August 1992. The second module was expected to go on commercial production by fourth quarter of year 1993. In 2008, the companyâ€™s name changed from Vamotiwala Chemical Industries Ltd to Caprolactam Chemicals Ltd.

The company has been promoted by Sarvashri Shankar G Bhanushali, Chandrakant K Pandya, Suresh H Nanda & their associates.

To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

Caprolactam Chemicals Ltd (507486)

Caprolactam Chemicals Ltd (507486)

Caprolactam Chemicals stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Caprolactam Chem. - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Caprolactam Chemicals Ltd FAQs

About Caprolactam Chemicals Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Caprolactam Chemicals Ltd (507486)

Caprolactam Chemicals Ltd (507486)

Caprolactam Chemicals stock performance

Check Before You Invest

M-Cap below 100cr DeciZen not available

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Value Creation ⓘ

Growth Parameters ⓘ

CAGR ⓘ

Key Financial Parameters ⓘ

Profit And Loss

Valuation of Caprolactam Chem. - Standalone

Price Calculator

Price Chart

Price to Earnings

Price to Sales

Price to Book

EV to EBITDA

Dividend History

Price Calculator

Price Chart

Price to Earnings

Enterprise Value to EBIT

Price to Book-Value

Price to Sales

Dividend History

Analyst's Notes

Balance Sheet

Equity and Liabilities

Fixed Assets

Cash Flow

Financial Ratio

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Caprolactam Chemicals Ltd FAQs

What is the share price of Caprolactam Chem.?

What is the market cap of Caprolactam Chem.?

What is the P/E ratio of Caprolactam Chem.?

What is the P/B ratio of Caprolactam Chem.?

What is the 52-week high and low of Caprolactam Chem.?

What is the TTM revenue of Caprolactam Chem.?

Is Caprolactam Chemicals Ltd a good quality company?

Is Caprolactam Chemicals Ltd undervalued or overvalued?

Is Caprolactam Chemicals Ltd a good buy now?

About Caprolactam Chemicals Ltd

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.